Pet Dewormers Market Size & Growth Forecast 2027–2036, By Segments (Type, Pet, Dosage Form, Route of Administration, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Pet Dewormers Market size stood at USD 2.9 billion in 2026 and is predicted to grow at a 8.74% CAGR from 2027 to 2036, exceeding USD 6.7 billion by 2036. The industry revenue for 2027 is estimated at USD 3.11 billion.
Get more details on this report
Request Free Sample ReportPet Dewormers Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 37.30% market share in 2026, supported by high pet ownership, routine veterinary care, preventive parasite management, and strong product availability through established distribution channels.
- Asia Pacific is projected to grow at a 9.83% CAGR as rising pet ownership, expanding veterinary services, and greater awareness of preventive parasite control increase routine deworming adoption.
Segment Momentum
- Prescription products held a 62.3% share in 2026 as veterinary oversight, accurate dosing, and targeted parasite treatment make them the preferred choice for both treatment and ongoing preventive care.
- Cats are the fastest-growing segment as awareness of feline parasite risks increases and more owners adopt dedicated deworming solutions based on veterinary guidance and preventive care practices.
Market Expansion Drivers
- Rising prevalence of parasite-borne diseases increasing year-round preventive deworming adoption.
- Growing pet humanization trends driving demand for premium broad-spectrum parasite protection products.
- Expanding veterinary telehealth and subscription care models improving preventive treatment compliance.
Leading Market Participants
- Leading players in the pet dewormers market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Merck & Co., Inc. (United States), Elanco Animal Health Incorporated (United States), Virbac S.A. (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals PLC (United Kingdom), Intas Pharmaceuticals Ltd. (India).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.9 billion
- 2027 Estimated Market Size: USD 3.11 billion.
- Projected Market Size: USD 6.7 billion by 2036
- Growth Forecast: 8.74% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Prescription (Type) | Dogs (Pet) | Tablets (Dosage Form) | Oral (Route of Administration) | Veterinary Hospitals/Clinics (Distribution Channel)
- Emerging Opportunity Segment: Prescription (Type) | Cats (Pet) | Liquids (Dosage Form) | Oral (Route of Administration) | E-commerce (Distribution Channel)
Market Growth Drivers and Industry Trends
Rising prevalence of parasite-borne diseases increasing year-round preventive deworming adoption
The continued occurrence of intestinal and other parasitic infections among companion animals is encouraging owners to adopt more consistent preventive care, which will drive the pet dewormers market growth. Parasites can affect animal health through gastrointestinal disturbances, nutritional deficiencies, weakened immunity, and other complications, increasing the importance of routine prevention and treatment. Greater awareness among pet owners about transmission risks and the benefits of regular veterinary care is shifting deworming from an occasional response to visible symptoms toward a more proactive component of pet healthcare. Seasonal parasite exposure in many regions, combined with pets' frequent outdoor activities and interaction with other animals, is also supporting demand for products suitable for recurring preventive treatment.
Growing pet humanization trends driving demand for premium broad-spectrum parasite protection products
As pets increasingly become regarded as family members, owners are placing greater emphasis on preventive healthcare and comprehensive protection, strengthening demand within the pet dewormers market. Pet humanization is encouraging consumers to seek products that offer broader parasite coverage, convenient administration, and formulations aligned with the overall health and comfort of companion animals. Owners are also becoming more attentive to veterinary recommendations and preventive healthcare routines, increasing interest in products designed to address multiple parasite risks rather than relying solely on treatment after infection occurs. Premiumization within pet care is further supporting demand for specialized deworming solutions that fit into broader wellness-oriented approaches to animal health.
Expanding veterinary telehealth and subscription care models improving preventive treatment compliance
Greater use of remote veterinary consultations and recurring pet-care services is making preventive treatment schedules easier for owners to manage, which will boost the pet dewormers market demand. Telehealth platforms can improve access to veterinary guidance, particularly for routine health concerns and follow-up care, while subscription models can support regular delivery of preventive products according to recommended treatment schedules. Automated reminders, recurring purchases, and digital communication with veterinary professionals can reduce the likelihood of missed deworming treatments and encourage greater adherence to preventive care routines. These models also create a more continuous relationship between pet owners and healthcare providers, allowing parasite prevention to become integrated into broader ongoing pet wellness management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of parasite-borne diseases increasing year-round preventive deworming adoption | 1.90% | Moderate | North America, Asia Pacific | High | Near Term |
| Growing pet humanization trends driving demand for premium broad-spectrum parasite protection products | 1.70% | Moderate | North America, Europe | High | Mid Term |
| Expanding veterinary telehealth and subscription care models improving preventive treatment compliance | 1.30% | Moderate | Europe, North America | Emerging | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for 37.30% of the pet dewormers market in 2026, reflecting high pet ownership, strong expenditure on companion animal healthcare, and widespread access to veterinary services. Greater awareness of preventive parasite control among pet owners supports regular deworming practices, while established veterinary networks and well-developed distribution channels make animal health products readily accessible. Increasing emphasis on preventive pet care is also reinforcing demand for treatments that help protect companion animals from parasitic infections.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, supported by increasing companion animal ownership, improving veterinary infrastructure, and rising awareness of routine pet healthcare. Urbanization and changing household structures are contributing to greater adoption of pets, while growing disposable incomes and expanding access to veterinary products are encouraging owners to invest more consistently in preventive parasite management.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Veterinary Compliance StandardsGermany emphasizes evidence-based parasite control supported by veterinary oversight and structured pet healthcare practices. The country's pet dewormers market encourages manufacturers to provide quality-assured formulations that align with responsible treatment protocols for companion animals.
France 🇫🇷
Routine Veterinary PreventionFrance maintains consistent demand for pet dewormers through established veterinary care and regular parasite prevention practices. The market favors reliable treatment schedules and products designed to support long-term health management for both dogs and cats.
Italy 🇮🇹
Expanding Companion CareItaly's pet dewormers market benefits from increasing investment in companion animal health and broader veterinary engagement. Growing awareness of parasite prevention is encouraging adoption of convenient treatment formats suited to routine pet healthcare across urban and regional markets.
Japan 🇯🇵
Companion Animal WellnessJapan's pet dewormers market reflects growing attention to companion animal health as aging pet populations receive more frequent veterinary care. Manufacturers are prioritizing easy-to-administer products and preventive treatment options that fit routine health management for household pets.
South Korea 🇰🇷
Premium Pet HealthcareSouth Korea is experiencing increasing demand for premium pet healthcare products, encouraging broader adoption of preventive deworming solutions. Veterinary clinics and specialty pet retailers support market expansion through greater owner education and access to innovative parasite control products.
United States 🇺🇸
Preventive Pet Care FocusThe U.S. pet dewormers market is supported by widespread preventive veterinary care and high awareness of parasite management among pet owners. Product demand increasingly favors convenient formulations, broad-spectrum protection, and integration with routine wellness programs across companion animal clinics.
Segment Leadership and Growth Trends
Pet Dewormers Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Prescription (Largest & Fastest-Growing Segment)
The prescription segment led the pet dewormers market in 2026 and accounted for a 62.3% share, while also representing the fastest-growing segment. Its strong position reflects the importance of veterinary guidance in selecting appropriate treatments based on parasite type, animal condition, species, and individual health requirements. Prescription-based products can provide targeted treatment under professional supervision, supporting responsible parasite management and reinforcing demand as pet owners place greater emphasis on preventive veterinary care.
Pet Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)
Dogs represented the largest segment of the pet dewormers market in 2026, with a 50.34% share, supported by their widespread ownership and frequent exposure to environments where intestinal and other parasitic infections can occur. Regular veterinary care, preventive treatment routines, and awareness of parasite-related health risks contribute to sustained demand for deworming products, while active lifestyles can increase the importance of consistent parasite management.
The cat segment is expanding as awareness of feline parasite prevention becomes more widespread among pet owners. Increased veterinary engagement and greater attention to preventive healthcare are encouraging more consistent use of deworming treatments for cats, while the growing humanization of pets is strengthening willingness to invest in routine health and wellness products.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | OTC, Prescription | Prescription | Prescription |
| Pet | Dogs, Cats, Horses, Others | Dogs | Cats |
| Dosage Form | Liquids, Tablets | Tablets | Liquids |
| Route of Administration | Oral, Injectable, Topical | Oral | Oral |
| Distribution Channel | Veterinary Hospitals/Clinics, Retail/Pet Stores, E-commerce | Veterinary Hospitals/Clinics | E-commerce |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Key companies in the pet dewormers market:
1. Zoetis Inc. (United States)
2. Boehringer Ingelheim International GmbH (Germany)
3. Merck & Co. Inc. (United States)
4. Elanco Animal Health Incorporated (United States)
5. Virbac S.A. (France)
6. Vetoquinol S.A. (France)
7. Ceva Santé Animale (France)
8. Dechra Pharmaceuticals PLC (United Kingdom)
9. Intas Pharmaceuticals Ltd. (India)
Increasing awareness regarding animal health and preventive care is strengthening competition in the pet dewormers market. Manufacturers are introducing broad-spectrum formulations, easy-to-administer dosage formats, and species-specific treatments to address diverse pet healthcare needs. Growing spending on companion animal wellness and expanding veterinary care access are also driving product innovation and market growth.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| Boehringer Ingelheim International GmbH (Germany) | |||||||
| Merck & Co. Inc. (United States) | |||||||
| Elanco Animal Health Incorporated (United States) | |||||||
| Virbac S.A. (France) | |||||||
| Vetoquinol S.A. (France) | |||||||
| Ceva Santé Animale (France) | |||||||
| Dechra Pharmaceuticals PLC (United Kingdom) | |||||||
| Intas Pharmaceuticals Ltd. (India). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Elanco | Nov-25 | Elanco received FDA Emergency Use Authorization for Credelio CAT to treat New World screwworm (NWS) infestations in cats. This authorization provides a critical therapeutic option in response to the parasite’s potential threat, underscoring the company’s role in zoonotic disease management and reinforcing its position as a key provider of specialized parasiticides in the veterinary health market. |
| Elanco | Sep-25 | Elanco’s Credelio Quattro achieved blockbuster status, reaching USD 100 million in net sales within eight months of launch. As a broad-spectrum isoxazoline endectocide, the product’s rapid commercial adoption reflects high demand for simplified, all-in-one parasite control solutions that address both external and internal infestations in dogs, significantly strengthening Elanco’s competitive positioning in the high-growth canine health segment. |
| Merck Animal Health | Jul-25 | Merck Animal Health received FDA approval for Bravecto Quantum, the first extended-release injectable for dogs providing 12 months of flea and tick protection. This technological innovation represents a significant shift in parasite control, moving from periodic oral or topical dosing to a single, veterinarian-administered injection, which enhances owner compliance and establishes a new standard for long-term clinical preventive care. |
| Zoetis | Jan-25 | Revolution Plus received FDA approval to prevent flea-transmitted tapeworm infections in cats. By expanding the product's label to include the prevention of Dipylidium caninum transmission, Zoetis has enhanced the clinical profile of its primary feline combination preventative, reinforcing its market-leading status by offering a more comprehensive solution for the management of common multi-parasite risks in feline health. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Pet Dewormers Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Parasite Type | Roundworms, Tapeworms, Hookworms, Whipworms, Heartworms |
| Treatment Purpose | Preventive Deworming, Therapeutic Treatment, Routine Parasite Control |
| Pet Age Group | Puppies & Kittens, Adult Pets, Senior Pets |
Pet Dewormers Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Veterinary Prescription and OTC Purchasing Behavior |
|
| Preventive Pet Healthcare Adoption |
|
| Pet Care Distribution Channel Evolution |
|
Need a different cut of the data?
Request Custom ResearchHow big is the pet dewormers market?
How is the pet dewormers industry expected to grow over the next 10 years?
How are evolving parasite risk patterns influencing preventive treatment adoption in the pet dewormers market?
How is pet humanization influencing demand for premium and broad-spectrum deworming solutions?
Why do Prescription products dominate the pet dewormers market?
Why are Cats the fastest-growing pet segment in the pet dewormers market?
What factors support North America's leadership in the pet dewormers market?
What is driving growth in the pet dewormers market across Asia Pacific?
Who are the major participants shaping the pet dewormers landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization